Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 408

1.

Purification and Functional Characterization of a Biologically Active Full-Length Feline Immunodeficiency Virus (FIV) Pr50Gag.

Krishnan A, Pillai VN, Chameettachal A, Mohamed Ali L, Nuzra Nagoor Pitchai F, Tariq S, Mustafa F, Marquet R, A Rizvi T.

Viruses. 2019 Jul 27;11(8). pii: E689. doi: 10.3390/v11080689.

2.

Stabilizing role of structural elements within the 5´ Untranslated Region (UTR) and gag sequences in Mason-Pfizer monkey virus (MPMV) genomic RNA packaging.

Kalloush RM, Vivet-Boudou V, Ali LM, Pillai VN, Mustafa F, Marquet R, Rizvi TA.

RNA Biol. 2019 May;16(5):612-625. doi: 10.1080/15476286.2019.1572424. Epub 2019 Feb 17.

PMID:
30773097
3.

The evolution of RNA structural probing methods: From gels to next-generation sequencing.

Mailler E, Paillart JC, Marquet R, Smyth RP, Vivet-Boudou V.

Wiley Interdiscip Rev RNA. 2019 Mar;10(2):e1518. doi: 10.1002/wrna.1518. Epub 2018 Nov 28. Review.

PMID:
30485688
4.

Expression, purification, and characterization of biologically active full-length Mason-Pfizer monkey virus (MPMV) Pr78Gag.

Pitchai FNN, Ali L, Pillai VN, Chameettachal A, Ashraf SS, Mustafa F, Marquet R, Rizvi TA.

Sci Rep. 2018 Aug 7;8(1):11793. doi: 10.1038/s41598-018-30142-0.

5.

The C-terminal p6 domain of the HIV-1 Pr55Gag precursor is required for specific binding to the genomic RNA.

Dubois N, Khoo KK, Ghossein S, Seissler T, Wolff P, McKinstry WJ, Mak J, Paillart JC, Marquet R, Bernacchi S.

RNA Biol. 2018;15(7):923-936. doi: 10.1080/15476286.2018.1481696. Epub 2018 Aug 4.

6.

The bifurcated stem loop 4 (SL4) is crucial for efficient packaging of mouse mammary tumor virus (MMTV) genomic RNA.

Mustafa F, Vivet-Boudou V, Jabeen A, Ali LM, Kalloush RM, Marquet R, Rizvi TA.

RNA Biol. 2018;15(8):1047-1059. doi: 10.1080/15476286.2018.1486661. Epub 2018 Jul 5.

7.

Biochemical and Functional Characterization of Mouse Mammary Tumor Virus Full-Length Pr77Gag Expressed in Prokaryotic and Eukaryotic Cells.

Chameettachal A, Pillai VN, Ali LM, Pitchai FNN, Ardah MT, Mustafa F, Marquet R, Rizvi TA.

Viruses. 2018 Jun 18;10(6). pii: E334. doi: 10.3390/v10060334.

8.

Structural and Functional Motifs in Influenza Virus RNAs.

Ferhadian D, Contrant M, Printz-Schweigert A, Smyth RP, Paillart JC, Marquet R.

Front Microbiol. 2018 Mar 29;9:559. doi: 10.3389/fmicb.2018.00559. eCollection 2018. Review.

9.

Retroviral RNA Dimerization: From Structure to Functions.

Dubois N, Marquet R, Paillart JC, Bernacchi S.

Front Microbiol. 2018 Mar 22;9:527. doi: 10.3389/fmicb.2018.00527. eCollection 2018. Review.

10.

In cell mutational interference mapping experiment (in cell MIME) identifies the 5' polyadenylation signal as a dual regulator of HIV-1 genomic RNA production and packaging.

Smyth RP, Smith MR, Jousset AC, Despons L, Laumond G, Decoville T, Cattenoz P, Moog C, Jossinet F, Mougel M, Paillart JC, von Kleist M, Marquet R.

Nucleic Acids Res. 2018 May 18;46(9):e57. doi: 10.1093/nar/gky152.

11.

Hijacking of the Ubiquitin/Proteasome Pathway by the HIV Auxiliary Proteins.

Seissler T, Marquet R, Paillart JC.

Viruses. 2017 Oct 31;9(11). pii: E322. doi: 10.3390/v9110322. Review.

12.

Translational regulation of APOBEC3G mRNA by Vif requires its 5'UTR and contributes to restoring HIV-1 infectivity.

Guerrero S, Libre C, Batisse J, Mercenne G, Richer D, Laumond G, Decoville T, Moog C, Marquet R, Paillart JC.

Sci Rep. 2016 Dec 20;6:39507. doi: 10.1038/srep39507.

13.

HIV-1 Pr55Gag binds genomic and spliced RNAs with different affinity and stoichiometry.

Bernacchi S, Abd El-Wahab EW, Dubois N, Hijnen M, Smyth RP, Mak J, Marquet R, Paillart JC.

RNA Biol. 2017 Jan 2;14(1):90-103. doi: 10.1080/15476286.2016.1256533. Epub 2016 Nov 14.

14.

MIMEAnTo: profiling functional RNA in mutational interference mapping experiments.

Smith MR, Smyth RP, Marquet R, von Kleist M.

Bioinformatics. 2016 Nov 1;32(21):3369-3370. Epub 2016 Jul 10.

PMID:
27402903
15.

The Life-Cycle of the HIV-1 Gag-RNA Complex.

Mailler E, Bernacchi S, Marquet R, Paillart JC, Vivet-Boudou V, Smyth RP.

Viruses. 2016 Sep 10;8(9). pii: E248. doi: 10.3390/v8090248. Review.

16.

Influenza NA and PB1 Gene Segments Interact during the Formation of Viral Progeny: Localization of the Binding Region within the PB1 Gene.

Gilbertson B, Zheng T, Gerber M, Printz-Schweigert A, Ong C, Marquet R, Isel C, Rockman S, Brown L.

Viruses. 2016 Aug 20;8(8). pii: E238. doi: 10.3390/v8080238.

17.

Packaging of Mason-Pfizer monkey virus (MPMV) genomic RNA depends upon conserved long-range interactions (LRIs) between U5 and gag sequences.

Kalloush RM, Vivet-Boudou V, Ali LM, Mustafa F, Marquet R, Rizvi TA.

RNA. 2016 Jun;22(6):905-19. doi: 10.1261/rna.055731.115. Epub 2016 Apr 19.

18.

Mutational interference mapping experiment (MIME) for studying RNA structure and function.

Smyth RP, Despons L, Huili G, Bernacchi S, Hijnen M, Mak J, Jossinet F, Weixi L, Paillart JC, von Kleist M, Marquet R.

Nat Methods. 2015 Sep;12(9):866-72. doi: 10.1038/nmeth.3490. Epub 2015 Aug 3.

PMID:
26237229
19.

[Reflections of the Ethics Group of CAMFiC on editorial attention to chronicity].

Reguant M, Planes A, Alcalá I, Amorós N, Batalla C, Fernández de Sanmamed MJ, Marquet R, Morera R, Peguero E, Riera L, Rubio M, Torrell G.

Aten Primaria. 2016 Jan;48(1):66-7. doi: 10.1016/j.aprim.2015.01.014. Epub 2015 May 16. Spanish. No abstract available.

20.

HIV-1 replication and the cellular eukaryotic translation apparatus.

Guerrero S, Batisse J, Libre C, Bernacchi S, Marquet R, Paillart JC.

Viruses. 2015 Jan 19;7(1):199-218. doi: 10.3390/v7010199. Review.

21.

Evaluation of anti-HIV-1 mutagenic nucleoside analogues.

Vivet-Boudou V, Isel C, El Safadi Y, Smyth RP, Laumond G, Moog C, Paillart JC, Marquet R.

J Biol Chem. 2015 Jan 2;290(1):371-83. doi: 10.1074/jbc.M114.616383. Epub 2014 Nov 14.

22.

Structural basis of genomic RNA (gRNA) dimerization and packaging determinants of mouse mammary tumor virus (MMTV).

Aktar SJ, Vivet-Boudou V, Ali LM, Jabeen A, Kalloush RM, Richer D, Mustafa F, Marquet R, Rizvi TA.

Retrovirology. 2014 Nov 14;11:96. doi: 10.1186/s12977-014-0096-6.

23.

[Catalonia's primary healthcare accreditation model: a valid model].

Davins J, Gens M, Pareja C, Guzmán R, Marquet R, Vallès R.

Med Clin (Barc). 2014 Jul;143 Suppl 1:74-80. doi: 10.1016/j.medcli.2014.07.015. Spanish.

PMID:
25128364
24.

Specific recognition of the HIV-1 genomic RNA by the Gag precursor.

Abd El-Wahab EW, Smyth RP, Mailler E, Bernacchi S, Vivet-Boudou V, Hijnen M, Jossinet F, Mak J, Paillart JC, Marquet R.

Nat Commun. 2014 Jul 2;5:4304. doi: 10.1038/ncomms5304.

PMID:
24986025
25.

Selective packaging of the influenza A genome and consequences for genetic reassortment.

Gerber M, Isel C, Moules V, Marquet R.

Trends Microbiol. 2014 Aug;22(8):446-55. doi: 10.1016/j.tim.2014.04.001. Epub 2014 May 2. Review.

PMID:
24798745
26.

SHAPE analysis of the 5' end of the Mason-Pfizer monkey virus (MPMV) genomic RNA reveals structural elements required for genome dimerization.

Aktar SJ, Jabeen A, Ali LM, Vivet-Boudou V, Marquet R, Rizvi TA.

RNA. 2013 Dec;19(12):1648-58. doi: 10.1261/rna.040931.113. Epub 2013 Oct 23.

27.

A functional sequence-specific interaction between influenza A virus genomic RNA segments.

Gavazzi C, Yver M, Isel C, Smyth RP, Rosa-Calatrava M, Lina B, Moulès V, Marquet R.

Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16604-9. doi: 10.1073/pnas.1314419110. Epub 2013 Sep 25.

28.

Critical role of segment-specific packaging signals in genetic reassortment of influenza A viruses.

Essere B, Yver M, Gavazzi C, Terrier O, Isel C, Fournier E, Giroux F, Textoris J, Julien T, Socratous C, Rosa-Calatrava M, Lina B, Marquet R, Moules V.

Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):E3840-8. doi: 10.1073/pnas.1308649110. Epub 2013 Sep 16.

29.

APOBEC3G impairs the multimerization of the HIV-1 Vif protein in living cells.

Batisse J, Guerrero SX, Bernacchi S, Richert L, Godet J, Goldschmidt V, Mély Y, Marquet R, de Rocquigny H, Paillart JC.

J Virol. 2013 Jun;87(11):6492-506. doi: 10.1128/JVI.03494-12. Epub 2013 Apr 10.

30.

An in vitro network of intermolecular interactions between viral RNA segments of an avian H5N2 influenza A virus: comparison with a human H3N2 virus.

Gavazzi C, Isel C, Fournier E, Moules V, Cavalier A, Thomas D, Lina B, Marquet R.

Nucleic Acids Res. 2013 Jan;41(2):1241-54. doi: 10.1093/nar/gks1181. Epub 2012 Dec 5.

31.

Interaction network linking the human H3N2 influenza A virus genomic RNA segments.

Fournier E, Moules V, Essere B, Paillart JC, Sirbat JD, Cavalier A, Rolland JP, Thomas D, Lina B, Isel C, Marquet R.

Vaccine. 2012 Dec 7;30(51):7359-67. doi: 10.1016/j.vaccine.2012.09.079. Epub 2012 Oct 9.

PMID:
23063835
32.

A pyrophosphatase activity associated with purified HIV-1 particles.

Ducloux C, Mougel M, Goldschmidt V, Didierlaurent L, Marquet R, Isel C.

Biochimie. 2012 Dec;94(12):2498-507. doi: 10.1016/j.biochi.2012.06.025. Epub 2012 Jul 3.

PMID:
22766015
33.

The role of Vif oligomerization and RNA chaperone activity in HIV-1 replication.

Batisse J, Guerrero S, Bernacchi S, Sleiman D, Gabus C, Darlix JL, Marquet R, Tisné C, Paillart JC.

Virus Res. 2012 Nov;169(2):361-76. doi: 10.1016/j.virusres.2012.06.018. Epub 2012 Jun 21. Review.

PMID:
22728817
34.

Initiation of HIV-1 reverse transcription and functional role of nucleocapsid-mediated tRNA/viral genome interactions.

Sleiman D, Goldschmidt V, Barraud P, Marquet R, Paillart JC, Tisné C.

Virus Res. 2012 Nov;169(2):324-39. doi: 10.1016/j.virusres.2012.06.006. Epub 2012 Jun 18. Review.

PMID:
22721779
35.

[A transcription factor acts as a HIV-1 accomplice to destroy the cellular defences].

Marquet R, Guerrero S, Bernacchi S, Pernot S, Batisse J, Paillart JC.

Med Sci (Paris). 2012 Apr;28(4):356-8. doi: 10.1051/medsci/2012284007. Epub 2012 Apr 25. French. No abstract available.

36.

HIV-1 polymerase inhibition by nucleoside analogs: cellular- and kinetic parameters of efficacy, susceptibility and resistance selection.

von Kleist M, Metzner P, Marquet R, Schütte C.

PLoS Comput Biol. 2012 Jan;8(1):e1002359. doi: 10.1371/journal.pcbi.1002359. Epub 2012 Jan 19.

37.

8-Modified-2'-deoxyadenosine analogues induce delayed polymerization arrest during HIV-1 reverse transcription.

Vivet-Boudou V, Isel C, Sleiman M, Smyth R, Ben Gaied N, Barhoum P, Laumond G, Bec G, Götte M, Mak J, Aubertin AM, Burger A, Marquet R.

PLoS One. 2011;6(11):e27456. doi: 10.1371/journal.pone.0027456. Epub 2011 Nov 7.

38.

A supramolecular assembly formed by influenza A virus genomic RNA segments.

Fournier E, Moules V, Essere B, Paillart JC, Sirbat JD, Isel C, Cavalier A, Rolland JP, Thomas D, Lina B, Marquet R.

Nucleic Acids Res. 2012 Mar;40(5):2197-209. doi: 10.1093/nar/gkr985. Epub 2011 Nov 10.

39.

Labeling of multiple HIV-1 proteins with the biarsenical-tetracysteine system.

Pereira CF, Ellenberg PC, Jones KL, Fernandez TL, Smyth RP, Hawkes DJ, Hijnen M, Vivet-Boudou V, Marquet R, Johnson I, Mak J.

PLoS One. 2011 Feb 11;6(2):e17016. doi: 10.1371/journal.pone.0017016.

40.

Importance of the proline-rich multimerization domain on the oligomerization and nucleic acid binding properties of HIV-1 Vif.

Bernacchi S, Mercenne G, Tournaire C, Marquet R, Paillart JC.

Nucleic Acids Res. 2011 Mar;39(6):2404-15. doi: 10.1093/nar/gkq979. Epub 2010 Nov 13.

41.

In vitro characterization of naturally occurring influenza H3NA- viruses lacking the NA gene segment: toward a new mechanism of viral resistance?

Moules V, Ferraris O, Terrier O, Giudice E, Yver M, Rolland JP, Bouscambert-Duchamp M, Bergeron C, Ottmann M, Fournier E, Traversier A, Boule C, Rivoire A, Lin Y, Hay A, Valette M, Marquet R, Rosa-Calatrava M, Naffakh N, Schoehn G, Thomas D, Lina B.

Virology. 2010 Sep 1;404(2):215-24. doi: 10.1016/j.virol.2010.04.030.

42.

Requests for euthanasia in general practice before and after implementation of the Dutch Euthanasia Act.

van Alphen JE, Donker GA, Marquet RL.

Br J Gen Pract. 2010 Apr;60(573):263-7. doi: 10.3399/bjgp10X483931.

43.

5-Modified-2'-dU and 2'-dC as mutagenic anti HIV-1 proliferation agents: synthesis and activity.

El Safadi Y, Paillart JC, Laumond G, Aubertin AM, Burger A, Marquet R, Vivet-Boudou V.

J Med Chem. 2010 Feb 25;53(4):1534-45. doi: 10.1021/jm901758f.

PMID:
20112915
44.

Initiation of HIV Reverse Transcription.

Isel C, Ehresmann C, Marquet R.

Viruses. 2010 Jan;2(1):213-43. doi: 10.3390/v2010213. Epub 2010 Jan 18.

45.

HIV-1 Vif binds to APOBEC3G mRNA and inhibits its translation.

Mercenne G, Bernacchi S, Richer D, Bec G, Henriet S, Paillart JC, Marquet R.

Nucleic Acids Res. 2010 Jan;38(2):633-46. doi: 10.1093/nar/gkp1009. Epub 2009 Nov 12.

46.

Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors.

Henriet S, Mercenne G, Bernacchi S, Paillart JC, Marquet R.

Microbiol Mol Biol Rev. 2009 Jun;73(2):211-32. doi: 10.1128/MMBR.00040-08. Review.

47.

The A-rich RNA sequences of HIV-1 pol are important for the synthesis of viral cDNA.

Keating CP, Hill MK, Hawkes DJ, Smyth RP, Isel C, Le SY, Palmenberg AC, Marshall JA, Marquet R, Nabel GJ, Mak J.

Nucleic Acids Res. 2009 Feb;37(3):945-56. doi: 10.1093/nar/gkn1015. Epub 2008 Dec 23.

48.

Advances in the structural understanding of Vif proteins.

Barraud P, Paillart JC, Marquet R, Tisné C.

Curr HIV Res. 2008 Mar;6(2):91-9. Review.

49.
50.

Synthesis and primary evaluation of novel HIV-1 inhibitors.

El Safadi Y, Marquet R, Aubertin AM, Vivet-Boudou V.

Nucleosides Nucleotides Nucleic Acids. 2007;26(8-9):1161-5.

PMID:
18058557

Supplemental Content

Loading ...
Support Center